A detailed history of Silverlake Wealth Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Silverlake Wealth Management LLC holds 5,561 shares of BMY stock, worth $318,812. This represents 0.11% of its overall portfolio holdings.

Number of Shares
5,561
Previous 5,558 0.05%
Holding current value
$318,812
Previous $231 Million 24.65%
% of portfolio
0.11%
Previous 0.09%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

BUY
$39.66 - $51.75 $118 - $155
3 Added 0.05%
5,561 $288 Million
Q2 2024

Aug 02, 2024

BUY
$40.25 - $52.99 $120 - $158
3 Added 0.05%
5,558 $231 Million
Q1 2024

Apr 18, 2024

BUY
$47.98 - $54.4 $95 - $108
2 Added 0.04%
5,555 $301 Million
Q4 2023

Jan 22, 2024

SELL
$48.48 - $57.85 $30,106 - $35,924
-621 Reduced 10.06%
5,553 $285 Million
Q3 2023

Oct 10, 2023

BUY
$57.89 - $64.73 $1,910 - $2,136
33 Added 0.54%
6,174 $358 Million
Q2 2023

Jul 25, 2023

SELL
$63.71 - $70.74 $1,783 - $1,980
-28 Reduced 0.45%
6,141 $393 Million
Q1 2023

Apr 12, 2023

SELL
$65.71 - $74.53 $79,574 - $90,255
-1,211 Reduced 16.41%
6,169 $428 Million
Q4 2022

Feb 15, 2023

BUY
$68.48 - $81.09 $505,382 - $598,444
7,380 New
7,380 $531 Million
Q3 2022

Apr 06, 2023

SELL
$0.13 - $76.84 $0 - $230
-3 Reduced 0.04%
7,376 $524 Million
Q2 2022

Apr 06, 2023

SELL
$72.62 - $79.98 $72 - $79
-1 Reduced 0.01%
7,379 $568 Million
Q1 2022

Apr 06, 2023

BUY
$61.48 - $73.72 $5,840 - $7,003
95 Added 1.33%
7,243 $529 Million
Q4 2021

Apr 06, 2023

SELL
$53.63 - $62.52 $12,442 - $14,504
-232 Reduced 3.14%
7,148 $446 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Silverlake Wealth Management LLC Portfolio

Follow Silverlake Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silverlake Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silverlake Wealth Management LLC with notifications on news.